Biotronics 3D, a developer of medical imaging software intended for widespread use by doctors, has received equity investment.

Biotronics 3D, a developer of medical imaging software intended for widespread use by doctors, has received equity investment.

The company secured £1 million from healthcare investor Longbow Capital, which manages £50 million of assets. With customers in the USA, Japan and Europe, Biotronics 3D plans to use the investment to develop more products and grow its global market share.

CEO Haralambos Hatzakis comments, ‘The democratisation of medical imaging is speeding up and Biotronics 3D intends to be a key global player in that process.’

Edward Rudd, a partner at Longbow Capital, says, ‘The increasing sophistication of imaging hardware requires innovative software to ensure that medical practitioners get the best from their investment.’

The global market for medical imaging is approaching $3 billion and growing at 15 per cent a year, according to consultant Frost & Sullivan.